187 related articles for article (PubMed ID: 27395443)
21. Apolipoprotein E ɛ4, Cognitive Function, and Pain Experience in Down Syndrome: A Pilot Study.
de Knegt NC; Schuengel C; Evenhuis HM; Lobbezoo F; Scherder EJ
Arch Clin Neuropsychol; 2016 Aug; 31(5):389-400. PubMed ID: 27193365
[TBL] [Abstract][Full Text] [Related]
22. Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.
Smith CJ; Ashford JW; Perfetti TA
J Alzheimers Dis; 2019; 68(3):885-923. PubMed ID: 30814349
[TBL] [Abstract][Full Text] [Related]
23. Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele.
Chen Y; Chen K; Zhang J; Li X; Shu N; Wang J; Zhang Z; Reiman EM
Neuropsychopharmacology; 2015 Mar; 40(5):1181-91. PubMed ID: 25403724
[TBL] [Abstract][Full Text] [Related]
24. Functional segregation loss over time is moderated by APOE genotype in healthy elderly.
Ng KK; Qiu Y; Lo JC; Koay ES; Koh WP; Chee MW; Zhou J
Hum Brain Mapp; 2018 Jul; 39(7):2742-2752. PubMed ID: 29520911
[TBL] [Abstract][Full Text] [Related]
25. The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients.
Valenza A; Bizzarro A; Marra C; Lauria A; Guglielmi V; Rossi C; Tiziano FD; Brahe C; Masullo C
Neurosci Lett; 2010 Mar; 472(3):199-203. PubMed ID: 20152880
[TBL] [Abstract][Full Text] [Related]
26. The APOE ɛ4 allele modulates brain white matter integrity in healthy adults.
Heise V; Filippini N; Ebmeier KP; Mackay CE
Mol Psychiatry; 2011 Sep; 16(9):908-16. PubMed ID: 20820167
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs.
Parcon PA; Balasubramaniam M; Ayyadevara S; Jones RA; Liu L; Shmookler Reis RJ; Barger SW; Mrak RE; Griffin WST
Alzheimers Dement; 2018 Feb; 14(2):230-242. PubMed ID: 28945989
[TBL] [Abstract][Full Text] [Related]
28. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
[TBL] [Abstract][Full Text] [Related]
29. APOE-ɛ4 effects on longitudinal decline in olfactory and non-olfactory cognitive abilities in middle-aged and old adults.
Josefsson M; Larsson M; Nordin S; Adolfsson R; Olofsson J
Sci Rep; 2017 Apr; 7(1):1286. PubMed ID: 28455505
[TBL] [Abstract][Full Text] [Related]
30. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
31. Impact of Personality on Cognitive Aging: A Prospective Cohort Study.
Caselli RJ; Dueck AC; Locke DE; Henslin BR; Johnson TA; Woodruff BK; Hoffman-Snyder C; Geda YE
J Int Neuropsychol Soc; 2016 Aug; 22(7):765-76. PubMed ID: 27346168
[TBL] [Abstract][Full Text] [Related]
32. Sex-Dependent Effects of the APOE ɛ4 Allele on Behavioral Traits and White Matter Structures in Young Adults.
Takeuchi H; Tomita H; Browne R; Taki Y; Kikuchi Y; Ono C; Yu Z; Nouchi R; Yokoyama R; Kotozaki Y; Nakagawa S; Sekiguchi A; Iizuka K; Hanawa S; Araki T; Miyauchi CM; Sakaki K; Nozawa T; Ikeda S; Yokota S; Magistro D; Sassa Y; Kawashima R
Cereb Cortex; 2021 Jan; 31(1):672-680. PubMed ID: 32954402
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E ɛ2/ɛ3/ɛ4 variant in association with obstructive sleep apnoea and lipid profile: A meta-analysis.
Lu Z; Wu X; Jin X; Peng F; Lin J
J Int Med Res; 2016 Feb; 44(1):3-14. PubMed ID: 26740500
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal DNA damage in APOE ɛ4 carriers and noncarriers does not appear to be different.
Chua A; Thomas P; Clifton P; Fenech M
Environ Mol Mutagen; 2015 Oct; 56(8):694-708. PubMed ID: 25820038
[TBL] [Abstract][Full Text] [Related]
35. Age-Related Effects of the Apolipoprotein E Gene on Brain Function.
Matura S; Prvulovic D; Hartmann D; Scheibe M; Sepanski B; Butz M; Oertel-Knöchel V; Knöchel C; Karakaya T; Fußer F; Hattingen E; Pantel J
J Alzheimers Dis; 2016 Mar; 52(1):317-31. PubMed ID: 27003211
[TBL] [Abstract][Full Text] [Related]
36. APOE ɛ4 constrains engagement of encoding-related compensatory networks in amnestic mild cognitive impairment.
Prieto del Val L; Cantero JL; Atienza M
Hippocampus; 2015 Sep; 25(9):993-1007. PubMed ID: 25616215
[TBL] [Abstract][Full Text] [Related]
37. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study.
Greenwood PM; Lambert C; Sunderland T; Parasuraman R
Neuropsychology; 2005 Mar; 19(2):199-211. PubMed ID: 15769204
[TBL] [Abstract][Full Text] [Related]
38. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
[TBL] [Abstract][Full Text] [Related]
39. 37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden.
Bäckman K; Joas E; Waern M; Östling S; Guo X; Blennow K; Skoog I; Gustafson DR
J Alzheimers Dis; 2015; 48(4):1119-27. PubMed ID: 26402098
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
